Pathway bridge based multiobjective optimization approach for lurking pathway prediction

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Ovarian carcinoma immunoreactive antigen-like protein 2 (OCIAD2) is a poorly understood protein implicated in various cancers.
• OCIAD2 expression is often reduced due to methylation, and its induction by TGFβ signaling is known.
• Existing pathway analysis tools struggle with genes lacking reported interactions or those with low expression levels.

Purpose of the Study:

• To investigate the biological context of OCIAD2, particularly within the tumor microenvironment.
• To identify novel pathways regulating OCIAD2 expression, especially those linked to TGFβ signaling.
• To develop a computational approach capable of analyzing genes with limited interaction data.

Main Methods:

• Development of a novel computational approach, pbMOO (pathway bridge-based module overlap optimization), to identify pathways.
• Application of pbMOO to analyze the TGFβ signaling pathway, focusing on ligand (TGFβ1), receptor (TGFβR1), and downstream components.
• Integration of protein-protein interaction networks and cancer-specific looping patterns to build pathway bridges.

Main Results:

• The pbMOO approach successfully identified a novel pathway: TGFβ1-TGFβR1-SMAD2/3-SMAD4/AR-OCIAD2.
• The androgen receptor (AR) was revealed as a potential transcription factor for OCIAD2 within the TGFβ signaling cascade.
• This pathway elucidates the mechanism by which TGFβ induces OCIAD2 expression in the cancer microenvironment.

Conclusions:

• The identified TGFβ1-TGFβR1-SMAD2/3-SMAD4/AR-OCIAD2 pathway provides a mechanistic explanation for OCIAD2 regulation in cancer.
• The androgen receptor plays a crucial role in mediating TGFβ-induced OCIAD2 expression.
• This study offers critical insights for future research into OCIAD2's function in tumor pathogenesis and provides a new tool for pathway analysis.